• <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置首页>技术资料首页>行业动态>新品动态>Abbott Labs 申请HIV病毒筛检上市许可

    Abbott Labs 申请HIV病毒筛检上市许可

    Abbott2010年9月13日 15:35 点击:2201

    美国雅培 Abbott
    (ABT) 54.71 +0.20 : 亚培(AbboTT Labs)宣布,向美国FDA申请ARCHITECT HIV Ag/Ab Combo分析法上市前许可(PMA)。

    Abbott  新闻稿

     Abbott Submits New HIV Test to FDA for Expedited Review

    Abbott Submits New HIV Test to FDA for Expedited Review

     

    January 25, 2010

    Abbott Park, Illinois, (NYSE: ABT) —An assay to aid in the early detection of HIV infection may soon be available in the United States. Abbott announced today it has submitted a Premarket Approval application for the ARCHITECT HIV Ag/Ab Combo assay to the U.S. Food and Drug Administration (FDA) for expedited review. Upon approval, the assay is expected to be the first test available in the United States to simultaneously detect the combined presence of HIV antigens (proteins produced by the HIV virus) and antibodies (proteins produced by the body to fight HIV antigens), which would allow for the early detection and ongoing monitoring of the virus.

    Studies conducted by researchers in the United States, including the Centers for Disease Control and Prevention (CDC), show that antibody-only tests fail to identify up to 10 percent of HIV infections in some high-incidence populations. However, the detection of the HIV p24 antigen enables laboratories to diagnose HIV infection before HIV antibodies are able to be detected. A combined antibody and antigen test holds considerable promise for HIV screening and could assist in detecting infections before antibodies can be identified.

    "The potential to diagnose HIV in the acute phase of the disease when antibodies are not yet present would be an important development in the fight against HIV," said Michael Warmuth, senior vice president, diagnostics, Abbott. "The earlier a patient can be diagnosed, the sooner the patient can be placed into care and the better chance there is to stop further spread of the virus."

    The Abbott-developed ARCHITECT assay was approved for use in Europe in 2004, and is currently an investigational device in the United States. The U.S. submission comes as Abbott marks the 25th year since the company developed the first FDA approved test for HIV. This latest submission underscores Abbott's continued commitment and leadership in HIV diagnostics.

    About ARCHITECT Ag/Ab HIV Combo Assay

    The ARCHITECT HIV Ag/Ab Combo assay is designed for the simultaneous qualitative detection of human immunodeficiency virus (HIV) p24 antigen and antibodies to HIV type 1 (HIV?1 group M and group O) and/or type 2 (HIV-2) in adult and pediatric serum and plasma. The assay is intended to be used as an aid in the diagnosis of HIV-1/HIV-2 infection, including acute or primary HIV-1 infection. It is also intended to be used as an aid in the diagnosis of HIV-1/HIV-2 infection in pregnant women.

    ARCHITECTHIV Ag/Ab Combo assay is not intended for use in screening blood, plasma or tissue donors. The effectiveness of ARCHITECTHIV Combo (Ag/Ab) for use in screening blood, plasma or tissue donors has not been established. The assay result does not distinguish between the detection of HIV p24 antigen, HIV-1 antibody, or HIV-2 antibody.

    About HIV

    The CDC estimates that there are 56,000 new cases of HIV in the United States annually. In 2008, UNAIDS estimated that 2.7 million people throughout the world are newly infected with HIV each year. Leading risk factors for HIV infection include male-to-male sexual contact, high-risk heterosexual contact and intravenous drug use.

    Abbott and HIV

    Abbott has been a leader in HIV/AIDS research since the early years of the epidemic. In 1985, the company developed the first licensed test to detect HIV antibodies in the blood and has marketed more than 20 HIV tests on six testing platforms to meet the unique customer needs in the United States and internationally. Abbott has developed two protease inhibitors for the treatment of HIV.

    About Abbott's Diagnostics Businesses

    Abbott is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics. With more than 69,000 customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, bedside testing, cost effectiveness and flexibility. Abbott has helped transform the practice of medical diagnosis from an art to a science through the company's commitment to improving patient care and lowering costs.

    About Abbott

    Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

     

     

    ARCHITECT is a trademark of Abbott Laboratories.

     
    Media:
    Darcy Ross

    (847) 937-3655
    Financial:
    Tina Ventura

    (847) 935-9390

     

    (来源: Abbott )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.67994619.com,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权?#20219;?#39064;,请在作品发表之日起一周内与本网联系,否则视为?#29260;?#30456;关权利。


    云南11选5技巧
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    河北十一选五高手预测 12580彩票投注 11选5任3口诀 公式六肖规律中特 山东体彩新11选5走势图 彩票开奖查询 数理分析网5肖中特 排列五开奖号码 幸运飞艇前四走势图 3d余数和分布图 第一台电子游戏机 竞彩网是不是合法的 26选5奖金 分析彩票的软件 江苏快三精准大小计划